发明名称 CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
摘要 Disclosed is a method and composition for treating tumors or infectious diseases, wherein the composition includes CD40 binding molecules together with CTL-activating peptides, e.g., tumor antigens. Such composition is useful for enhancing the anti-tumor effect of a peptide tumor vaccine, or for otherwise activating CTLs so that the activated CTLs can act against tumorous or infected cells. The CD40 binding molecules can include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like Fab, F(ab')2 and Fv, as well as other molecules including peptides, oligonucleotides, peptidomimetics and organic compounds which bind to CD40 and activate the CTL response.
申请公布号 US2009285814(A1) 申请公布日期 2009.11.19
申请号 US20090505022 申请日期 2009.07.17
申请人 UNIVERSITY HOSPITAL LEIDEN 发明人 MELIEF CORNELIS J. M.;SCHOENBERGER STEPHEN P.;OFFRINGA RIENK;TOES RENE
分类号 A61K39/395;C12N15/09;A61K35/12;A61K38/00;A61K45/00;A61K48/00;A61P31/12;A61P35/00;C07K14/025;C07K14/075;C07K14/47;C07K16/18;C07K16/28;C12N1/15;C12N1/19;C12N1/21;C12N5/10 主分类号 A61K39/395
代理机构 代理人
主权项
地址